[HTML][HTML] Recent progress and considerations for AAV gene therapies targeting the central nervous system
EA Lykken, C Shyng, RJ Edwards, A Rozenberg… - Journal of …, 2018 - Springer
Background Neurodevelopmental disorders, as a class of diseases, have been particularly
difficult to treat even when the underlying cause (s), such as genetic alterations, are …
difficult to treat even when the underlying cause (s), such as genetic alterations, are …
Recent progress and considerations for AAV gene therapies targeting the central nervous system.
EA Lykken, C Shyng, RJ Edwards… - Journal of …, 2018 - europepmc.org
Background Neurodevelopmental disorders, as a class of diseases, have been particularly
difficult to treat even when the underlying cause (s), such as genetic alterations, are …
difficult to treat even when the underlying cause (s), such as genetic alterations, are …
Recent progress and considerations for AAV gene therapies targeting the central nervous system
EA Lykken, C Shyng… - Journal of …, 2018 - utsouthwestern.elsevierpure.com
Background: Neurodevelopmental disorders, as a class of diseases, have been particularly
difficult to treat even when the underlying cause (s), such as genetic alterations, are …
difficult to treat even when the underlying cause (s), such as genetic alterations, are …
Recent progress and considerations for AAV gene therapies targeting the central nervous system
EA Lykken, C Shyng, RJ Edwards… - Journal of …, 2018 - pubmed.ncbi.nlm.nih.gov
Background Neurodevelopmental disorders, as a class of diseases, have been particularly
difficult to treat even when the underlying cause (s), such as genetic alterations, are …
difficult to treat even when the underlying cause (s), such as genetic alterations, are …
Recent progress and considerations for AAV gene therapies targeting the central nervous system
EA Lykken, C Shyng, RJ Edwards… - Journal of …, 2018 - go.gale.com
Background Neurodevelopmental disorders, as a class of diseases, have been particularly
difficult to treat even when the underlying cause (s), such as genetic alterations, are …
difficult to treat even when the underlying cause (s), such as genetic alterations, are …
[引用][C] Recent progress and considerations for AAV gene therapies targeting the central nervous system
EA Lykken, C Shyng, RJ Edwards… - Journal of …, 2018 - cir.nii.ac.jp
Recent progress and considerations for AAV gene therapies targeting the central nervous
system | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …
system | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …
Recent progress and considerations for AAV gene therapies targeting the central nervous system.
EA Lykken, C Shyng, RJ Edwards… - Journal of …, 2018 - search.ebscohost.com
Background: Neurodevelopmental disorders, as a class of diseases, have been particularly
difficult to treat even when the underlying cause (s), such as genetic alterations, are …
difficult to treat even when the underlying cause (s), such as genetic alterations, are …
[HTML][HTML] Recent progress and considerations for AAV gene therapies targeting the central nervous system
EA Lykken, C Shyng… - Journal of …, 2018 - jneurodevdisorders.biomedcentral …
Neurodevelopmental disorders, as a class of diseases, have been particularly difficult to
treat even when the underlying cause (s), such as genetic alterations, are understood. What …
treat even when the underlying cause (s), such as genetic alterations, are understood. What …
Recent progress and considerations for AAV gene therapies targeting the central nervous system
EA Lykken, C Shyng, RJ Edwards… - Journal of …, 2018 - cdr.lib.unc.edu
Background: Neurodevelopmental disorders, as a class of diseases, have been particularly
difficult to treat even when the underlying cause (s), such as genetic alterations, are …
difficult to treat even when the underlying cause (s), such as genetic alterations, are …
[HTML][HTML] Recent progress and considerations for AAV gene therapies targeting the central nervous system
EA Lykken, C Shyng, RJ Edwards… - Journal of …, 2018 - ncbi.nlm.nih.gov
Background Neurodevelopmental disorders, as a class of diseases, have been particularly
difficult to treat even when the underlying cause (s), such as genetic alterations, are …
difficult to treat even when the underlying cause (s), such as genetic alterations, are …